MADISON, Wis., Aug. 1, 2017 /PRNewswire/ -- Exact Sciences
Corp. (Nasdaq: EXAS) today announced that the company will participate in the 37th Annual Canaccord Genuity Growth Conference on
Wednesday, Aug. 9.
Jeff Elliott, Exact Sciences' chief financial officer, will make the company's presentation at
the conference at 12 p.m. ET in Boston.
About Exact Sciences Corp.
Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms
of cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the
detection of colorectal cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences or find
Exact Sciences on Facebook.
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the "safe harbor"
created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans,
strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may,"
"will," "should," "could," "seek," "intend," "plan," "goal," "estimate," "anticipate" or other comparable terms. All statements
other than statements of historical facts included in this news release regarding our strategies, prospects, financial condition,
operations, costs, plans and objectives are forward-looking statements. Examples of forward-looking statements include, among
others, statements we make regarding expected future operating results, anticipated results of our sales and marketing efforts,
expectations concerning payer reimbursement and the anticipated results of our product development efforts. Forward-looking
statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current
beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated
events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are
subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside
of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking
statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our
actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among
others, the following: our ability to successfully and profitably market our products and services; the acceptance of our
products and services by patients and healthcare providers; our ability to meet demand for our products and services; the
willingness of health insurance companies and other payers to cover Cologuard and reimburse us for our performance of the
Cologuard test; the amount and nature of competition from other cancer screening products and services; the effects of the
adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in
healthcare pricing, coverage and reimbursement; recommendations, guidelines and quality metrics issued by various organizations
such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance
regarding cancer screening or our products and services; our ability to successfully develop new products and services; our
success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory
approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in
Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual
Report on Form 10-K and our subsequently filed Quarterly Report(s) on Form 10-Q. We undertake no obligation to publicly update
any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new
information, future developments or otherwise.
Contact:
Megan Reiss
Exact Sciences Corp.
Investor Relations Analyst
meganreiss@exactsciences.com
608-535-8815
View original content with multimedia:http://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-canaccord-genuity-growth-conference-300497020.html
SOURCE EXACT SCIENCES CORP